Cardiome Pharma Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 4,511 789 1,505 66,064
Cost of Revenue 936 - - -
Gross Profit 3,575 789 1,505 66,064
Operating Expenses
Research and Development 476 6,017 15,224 15,339
Sales, General and Admin. 16,446 9,463 11,549 12,875
Non-Recurring Items 2,701 10,040 95 25
Other 649 1,229 1,095 1,154
Operating Income (16,697) (25,960) (26,458) 36,671
Income From Continuing Operations
Add'l Income/Expense Items 21,659 11,913 756 803
Earnings Before Interest and Tax 4,962 (14,047) (25,702) 37,474
Interest Expense 87 4,268 2,218 1,975
Earnings Before Tax 4,875 (18,315) (27,920) 35,499
Income Tax 102 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 25,607 (7,097) (27,920) 35,499
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 4,773 (18,315) (27,920) 35,499
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 4,773 (18,315) (27,920) 35,499